VWC2
Brorin
Also known as: PSST739, UNQ739, VWC2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q2TAL6
- Gene
- VWC2
- Ensembl
- ENSG00000188730
- Chromosome
- 7
- Canonical length
- 325 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
This gene encodes a secreted bone morphogenic protein antagonist. The encoded protein is possibly involved in neural function and development and may have a role in cell adhesion.[provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
325 residues, UniProt reviewed canonical sequence.
>Q2TAL6|VWC2
1 MPSSTAMAVG ALSSSLLVTC CLMVALCSPS IPLEKLAQAP EQPGQEKREH ASRDGPGRVN
61 ELGRPARDEG GSGRDWKSKS GRGLAGREPW SKLKQAWVSQ GGGAKAGDLQ VRPRGDTPQA
121 EALAAAAQDA IGPELAPTPE PPEEYVYPDY RGKGCVDESG FVYAIGEKFA PGPSACPCLC
181 TEEGPLCAQP ECPRLHPRCI HVDTSQCCPQ CKERKNYCEF RGKTYQTLEE FVVSPCERCR
241 CEANGEVLCT VSACPQTECV DPVYEPDQCC PICKNGPNCF AETAVIPAGR EVKTDECTIC
301 HCTYEEGTWR IERQAMCTRH ECRQMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against VWC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 10 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 10 nTPM
- heart muscle: 4.6 nTPM
- ovary: 3.7 nTPM
- amygdala: 2.2 nTPM
- cerebral cortex: 1.9 nTPM
- hypothalamus: 1.8 nTPM
Single-cell type
- retinal ganglion cells: 518 nCPM
- retinal bipolar cells: 413 nCPM
- granulosa cells: 280 nCPM
- rod photoreceptor cells: 270 nCPM
- oligodendrocyte progenitor cells: 258 nCPM
- brain excitatory neurons: 148 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 21 nTPM
- thalamus: 11 nTPM
- cerebral cortex: 7.8 nTPM
- amygdala: 7.6 nTPM
- midbrain: 6.2 nTPM
- hypothalamus: 5.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.27
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 1.67
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of BMP signaling pathway
- neurotransmitter receptor localization to postsynaptic specialization membrane
- positive regulation of cell-substrate adhesion
- positive regulation of neuron differentiation
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of VWC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VWC2 as an antibody target. Whether an autoantibody or antibody against VWC2 could matter depends on whether native VWC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VWC2 is annotated as secreted, so native VWC2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label VWC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...